Drug: ondansetron Quarter: 2016Q3
Total Records: 1,451 Number of Pages: 73
DRUGNAME | PT | EventCount |
---|---|---|
ONDANSETRONE RANBAXY | Congenital anomaly | 1 |
ONDANSETRONE RANBAXY | Foetal exposure during pregnancy | 1 |
ONDANSETRONE RANBAXY | Gastrooesophageal reflux disease | 1 |
ONDANSETRONE RANBAXY | Hyperkalaemia | 1 |
ONDANSETRONE RANBAXY | Intervertebral disc degeneration | 1 |
ONDANSETRONE RANBAXY | Laryngomalacia | 1 |
ONDANSETRONE RANBAXY | Maternal exposure during pregnancy | 1 |
ONDANSETRONE RANBAXY | Micrognathia | 1 |
ONDANSETRONE RANBAXY | Multiple congenital abnormalities | 1 |
ONDANSETRONE RANBAXY | Overweight | 1 |
ONDANSETRONE RANBAXY | Pierre Robin syndrome | 1 |
ONDANSETRONE RANBAXY | Product use issue | 1 |
ONDANSETRONE RANBAXY | Renal failure | 1 |
ONDANSETRONE RANBAXY | Renal hypertension | 1 |
ONDANSETRONE TEVA | Anhedonia | 1 |
ONDANSETRONE TEVA | Atrial septal defect | 1 |
ONDANSETRONE TEVA | Cardiomegaly | 1 |
ONDANSETRONE TEVA | Cardiopulmonary failure | 1 |
ONDANSETRONE TEVA | Deformity | 1 |
ONDANSETRONE TEVA | Ebstein's anomaly | 1 |
Total Records: 1,451 Number of Pages: 73